Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Repligen Q3 Adj. EPS $0.46 Beats $0.42 Estimate, Sales $188.805M Beat $181.338M Estimate

Author: Benzinga Newsdesk | October 28, 2025 06:30am
Repligen (NASDAQ:RGEN) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.42 by 10.05 percent. This is a 6.98 percent increase over earnings of $0.43 per share from the same period last year. The company reported quarterly sales of $188.805 million which beat the analyst consensus estimate of $181.338 million by 4.12 percent. This is a 21.91 percent increase over sales of $154.871 million the same period last year.

Posted In: RGEN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist